Literature DB >> 7959709

Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.

M Tanaka1, H Fukuda, K Hirai, M Hosaka, T Matsumoto, J Kumazawa.   

Abstract

OBJECTIVE: To investigate the alteration of cell permeability toward fluoroquinolones in Neisseria gonorrhoeae, which is a major quinolone-resistance mechanism along with the alteration of DNA gyrase in gram-negative bacteria. The prevalence of fluoroquinolone-resistant N gonorrhoeae strains is rapidly increasing in Japan.
MATERIALS AND METHODS: The uptake and accumulation of norfloxacin by gonococcal cells, including six clinical and five World Health Organization (WHO) reference strains, were measured. Of the six clinical strains, two were highly resistant to norfloxacin (MIC 8.0 and 4.0 micrograms/ml), two were moderately resistant (MIC 1.0 and 0.5 microgram/ml), and two were sensitive (MIC 0.063 and 0.004 microgram/ml). All five WHO reference strains were sensitive to norfloxacin (MIC < or = 0.001 to 0.063 microgram/ml).
RESULTS: Mean initial norfloxacin uptake in the four resistant strains (104 ng/mg of dry cells) was significantly lower than that in the seven sensitive strains (158 ng/mg of dry cells) (p < 0.05). The mean uptake after 20 minutes was also significantly lower in the four resistant strains (130 ng/mg of dry cells) than in the seven sensitive strains (194 ng/mg of dry cells) (p < 0.05). However, there was no significant difference in mean norfloxacin accumulation after 20 minutes between the four resistant strains (26 ng/mg of dry cells) and the seven sensitive strains (36 ng/mg of dry cells). The accumulation of norfloxacin after 20 minutes was almost zero in two of the four resistant strains, while the remaining two strains accumulated norfloxacin as well as the sensitive strains.
CONCLUSIONS: These findings suggest that alteration of bacterial cell permeability is a quinolone-resistance mechanism in N gonorrhoeae isolated in Japan, and that this bacteria may exhibit other mechanisms such as alteration of DNA gyrase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959709      PMCID: PMC1195249          DOI: 10.1136/sti.70.4.253

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  20 in total

1.  Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.

Authors:  J E Corkill; A Percival; M Lind
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

2.  Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae.

Authors:  C A Ison; N S Branley; K Kirtland; C S Easmon
Journal:  BMJ       Date:  1991-11-23

3.  Ciprofloxacin resistance in gonococci.

Authors:  A E Jephcott; A Turner
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

4.  Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  W R Gransden; C A Warren; I Phillips; M Hodges; D Barlow
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

5.  Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection.

Authors:  J R Black; J M Long; B E Zwickl; B S Ray; M S Verdon; S Wetherby; E W Hook; H H Handsfield
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

6.  Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.

Authors:  K M Pabst; N A Siegel; S Smith; J R Black; H H Handsfield; E W Hook
Journal:  Sex Transm Dis       Date:  1989 Jul-Sep       Impact factor: 2.830

7.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

8.  High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.

Authors:  M Tanaka; J Kumazawa; T Matsumoto; I Kobayashi
Journal:  Genitourin Med       Date:  1994-04

9.  Single dose ciprofloxacin for treating gonococcal infections in men.

Authors:  P S Loo; G L Ridgway; J D Oriel
Journal:  Genitourin Med       Date:  1985-10

10.  Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.

Authors:  K Panikabutra; C T Lee; B Ho; P Bamberg
Journal:  Genitourin Med       Date:  1988-08
View more
  8 in total

1.  Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.

Authors:  D L Trees; A L Sandul; W L Whittington; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

2.  Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones.

Authors:  T Deguchi; M Yasuda; M Nakano; E Kanematsu; S Ozeki; Y Nishino; T Ezaki; S Maeda; I Saito; Y Kawada
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

3.  Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.

Authors:  M Tanaka; T Matsumoto; M Sakumoto; K Takahashi; T Saika; I Kabayashi; J Kumazawa
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones.

Authors:  T Deguchi; M Yasuda; M Nakano; S Ozeki; T Ezaki; S Maeda; I Saito; Y Kawada
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.

Authors:  Wenming Zhou; Weidong Du; Huimin Cao; Jianlong Zhao; Sen Yang; Wei Li; Yujun Shen; Shumei Zhang; Wenhui Du; Xuejun Zhang
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.

Authors:  M Tanaka; M Otsuki; T Nishino; I Kobayashi; T Matsumoto; J Kumazawa
Journal:  Genitourin Med       Date:  1996-08

7.  Quinolone Resistance in Neisseria gonorrhoeae.

Authors:  Janine R. Tompkins; Jonathan M. Zenilman
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

8.  Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.

Authors:  M Tanaka; S Sakuma; K Takahashi; T Nagahuzi; T Saika; I Kobayashi; J Kumazawa
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.